论文部分内容阅读
2010年7月中旬,由国务院纠风办、卫生部、国家发改委、监察部、财政部、国家工商总局、国家食品药品监管局等7部门联合签发的《药品集中采购监督管理办法》、《医疗机构药品集中采购工作规范》(以下简称《办法》、《规范》)正式颁布实施。以政府为主导、以省为单位,坚持质量优先、价格合理,全程监管医疗机构行为等原则在新规中得以明确。《办法》规定,参与集中采购的药企在采购周期内涨价将依法给予处理。卫生部相关负责人表示,《办法》、《规范》的监管对象涵盖参与药品采购工作
In mid-July 2010, the Measures for the Supervision and Administration of Centralized Drug Purchases issued jointly by the Office of Corrective Affairs Office of the State Council, Ministry of Health, National Development and Reform Commission, Ministry of Supervision, Ministry of Finance, State Administration for Industry and Commerce and State Food and Drug Administration, Drug procurement centralized procurement norms “(hereinafter referred to as” measures “,” norms “) was promulgated and implemented. Government-led, province-based, adhere to the quality of priority, the price is reasonable, full supervision of medical institutions and other principles in the new rules to be clear. The Measures stipulate that prices of pharmaceutical companies participating in centralized purchasing will be dealt with according to law within the procurement cycle. The relevant person in charge of the Ministry of Health said that the ”measures“ and ”norms" of the regulatory targets include participation in drug procurement work